Screener
Vertex Pharmaceuticals VRTX Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Vertex Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The source filing: Vertex Pharmaceuticals’s 8-K, filed August 3, 2026. Open the filing →
- Filed
- Aug 3, 2026, 4:09 PM EDT
- Accession
- 0000875320-26-000256
FAQ
- What is Vertex Pharmaceuticals's total costs & expenses?
- Vertex Pharmaceuticals (VRTX) reported total costs & expenses of $2.09B in Q2 2026.
- How has Vertex Pharmaceuticals's total costs & expenses changed year-over-year?
- Vertex Pharmaceuticals's total costs & expenses increased by 15.1% year-over-year, from $1.81B to $2.09B.
- What is the long-term trend for Vertex Pharmaceuticals's total costs & expenses?
- Over 4 years (2021 to 2025), Vertex Pharmaceuticals's total costs & expenses has grown at a 13.1% compound annual growth rate (CAGR), from $4.79B to $7.83B.
Ask your AI about Vertex Pharmaceuticals's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude